ARCHIVES

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

In Brief: Nurses Association Endorses Clinton-Gore; Levin Heads New Society For Neuro-Oncology

June 28, 1996

NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network

March 12, 2010

Fox Chase Forms Network Of Oncologists

February 9, 1996

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

In Brief: FCRF Contract Hopefuls Make Oral Presentation; Jane Rowley To Deliver Karnofsky Lecture

April 10, 1987